Insmed Inc [NASDAQ: INSM] plunged by -$0.73 during the normal trading session on while it closed the day at $74.14.
Insmed Inc stock has also gained 3.24% of its value over the past 7 days. However, INSM stock has inclined by 197.39% in the 3 months of the year. Over the past six months meanwhile, it has gained 170.19% and gained 139.24% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for INSM stock reached $12.74 billion, with 171.85 million shares outstanding and 166.87 million shares in the current float. Compared to the average trading volume of 3.53M shares, INSM reached a trading volume of 2851379 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Insmed Inc [INSM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INSM shares is $87.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INSM stock is a recommendation set at 1.06. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Truist have made an estimate for Insmed Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 23, 2024. While these analysts kept the previous recommendation, Wolfe Research raised their target price to Outperform. The new note on the price target was released on February 15, 2024, representing the official price target for Insmed Inc stock. Previously, the target price had yet another raise to $55, while Wells Fargo analysts kept a Overweight rating on INSM stock.
The Average True Range (ATR) for Insmed Inc is set at 3.22, with the Price to Sales ratio for INSM stock in the period of the last 12 months amounting to 38.77. The Price to Book ratio for the last quarter was 318.32, with the Price to Cash per share for the same quarter was set at 7.26.
INSM stock trade performance evaluation
Insmed Inc [INSM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.24. With this latest performance, INSM shares dropped by -1.85% in over the last four-week period, additionally plugging by 170.19% over the last 6 months – not to mention a rise of 229.36% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for INSM stock in for the last two-week period is set at 55.45, with the RSI for the last a single of trading hit 52.63, and the three-weeks RSI is set at 58.84 for Insmed Inc [INSM]. The present Moving Average for the last 50 days of trading for this stock 70.00, while it was recorded at 74.69 for the last single week of trading, and 38.51 for the last 200 days.
Insmed Inc [INSM]: An insightful look at the core fundamentals
Insmed Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.53 and a Current Ratio set at 2.71.
Insmed Inc [INSM]: Institutional Ownership
The top three institutional holders of INSM stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in INSM stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in INSM stock with ownership which is approximately 5.1238%.
